1 – 7 of 7
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Trajectories of immune-related serum proteins and quality of life in patients with pancreatic and other periampullary cancer : the CHAMP study
(
- Contribution to journal › Article
-
Mark
Sex and gender differences in treatment intention, quality of life and performance status in the first 100 patients with periampullary cancer enrolled in the CHAMP study
(
- Contribution to journal › Article
- 2022
-
Mark
Branching copy number evolution and parallel immune profiles across the regional tumor space of resected pancreatic cancer
(
- Contribution to journal › Article
-
Mark
PRR11 unveiled as a top candidate biomarker within the RBM3-regulated transcriptome in pancreatic cancer
(
- Contribution to journal › Article
- 2020
-
Mark
Chemotherapy, host response and molecular dynamics in periampullary cancer : The CHAMP study
(
- Contribution to journal › Article
- 2019
-
Mark
Mutational Landscape in Resected Periampullary Adenocarcinoma: Relationship With Morphology and Clinical Outcome
(
- Contribution to journal › Article
- 2018
-
Mark
A translational effort to identify prognostic and predictive biomarkers in pancreatic cancer among RBM3-regulated genes
(
- Contribution to conference › Poster